Stocks and Investing
Stocks and Investing
Tue, February 15, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, February 14, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jeffrey Hung Initiated (BCYC) at Hold and Held Target at $60 on, Feb 14th, 2022
Jeffrey Hung of Morgan Stanley, Initiated "Bicycle Therapeutics plc" (BCYC) at Hold and Held Target at $60 on, Feb 14th, 2022.
Jeffrey has made no other calls on BCYC in the last 4 months.
There are 3 other peers that have a rating on BCYC. Out of the 3 peers that are also analyzing BCYC, 0 agree with Jeffrey's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Jeffrey
- Jonathan Chang of "SVB Leerink" Initiated at Buy and Held Target at $70 on, Friday, December 17th, 2021
- Ami Fadia of "Needham" Initiated at Strong Buy and Held Target at $85 on, Thursday, December 9th, 2021
- Reni Benjamin of "JMP Securities" Maintained at Buy with Increased Target to $85 on, Thursday, October 14th, 2021
Contributing Sources